{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T23:07:17Z","timestamp":1776467237836,"version":"3.51.2"},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1016\/j.leukres.2005.05.017","type":"journal-article","created":{"date-parts":[[2005,7,26]],"date-time":"2005-07-26T19:00:16Z","timestamp":1122404416000},"page":"109-114","source":"Crossref","is-referenced-by-count":34,"title":["Pure red cell aplasia in B-cell lymphoproliferative disorder treated with rituximab: Report of two cases and review of the literature"],"prefix":"10.1016","volume":"30","author":[{"given":"Kalyani","family":"Narra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hossein","family":"Borghaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tahseen","family":"Al-Saleem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"H\u00f6glund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitchell R.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.leukres.2005.05.017_bib1","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/00005792-198609000-00006","article-title":"Pure red-cell aplasia in patients with chronic lymphocytic leukaemia","volume":"65","author":"Chikkappa","year":"1986","journal-title":"Medicine (Baltimore)"},{"issue":"7","key":"10.1016\/j.leukres.2005.05.017_bib2","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1182\/blood.V87.7.3000.bloodjournal8773000","article-title":"Pure red cell aplasia: association with large granular lymphocyte leukemia and the prognostic value of cytogenetic abnormalities","volume":"87","author":"Lacy","year":"1996","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.leukres.2005.05.017_bib3","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1046\/j.1365-2141.2000.02429.x","article-title":"Pure red cell aplasia","volume":"111","author":"Fisch","year":"2000","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.leukres.2005.05.017_bib4","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1128\/CMR.15.3.485-505.2002","article-title":"Human parvovirus B19","volume":"15","author":"Heegaard","year":"2002","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"10.1016\/j.leukres.2005.05.017_bib5","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1046\/j.1365-2141.2002.37668.x","article-title":"Red cell aplasia due to parvovirus b19 in a patient treated with alemtuzumab","volume":"119","author":"Crowley","year":"2002","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.leukres.2005.05.017_bib6","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1046\/j.1365-2141.2002.03778.x","article-title":"Pure red cell aplasia due to parvovirus following treatment with CHOP and rituximab for B-cell lymphoma*","volume":"119","author":"Song","year":"2002","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.leukres.2005.05.017_bib7","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1182\/blood-2002-09-2923","article-title":"Pure red-cell aplasia due to parvovirus B19 infection in a patient treated with alemtuzumab","volume":"101","author":"Herbert","year":"2003","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.leukres.2005.05.017_bib8","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1182\/blood.V96.3.1184","article-title":"Pure red cell aplasia due to parvovirus B19 in a patient treated with rituximab","volume":"96","author":"Sharma","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2005.05.017_bib9","unstructured":"Hematology: Basic Principles and Practice. 3rd ed.; 2000."},{"issue":"6","key":"10.1016\/j.leukres.2005.05.017_bib10","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1182\/blood.V100.6.2260","article-title":"Rituximab treatment of refractory fludarabine-associated immune thrombocytopenia in chronic lymphocytic leukemia","volume":"100","author":"Hegde","year":"2002","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.leukres.2005.05.017_bib11","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1038\/sj.leu.2402676","article-title":"Rituximab-based chemotherapy for steroid-refractory autoimmune hemolytic anemia of chronic lymphocytic leukemia","volume":"16","author":"Gupta","year":"2002","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.leukres.2005.05.017_bib12","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1182\/blood.V99.3.1092","article-title":"Successful treatment of pure red cell aplasia with rituximab in patients with chronic lymphocytic leukemia","volume":"99","author":"Ghazal","year":"2002","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.leukres.2005.05.017_bib13","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1046\/j.1365-2141.2002.36892.x","article-title":"Successful response to rituximab in a patient with pure red cell aplasia complicating chronic lymphocytic leukaemia","volume":"118","author":"Batlle","year":"2002","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.leukres.2005.05.017_bib14","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1046\/j.1365-2141.2003.04609.x","article-title":"Successful treatment of refractory pure red cell aplasia associated with lymphoproliferative disorders with the anti-CD52 monoclonal antibody alemtuzumab (Campath-1H)","volume":"123","author":"Ru","year":"2003","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.leukres.2005.05.017_bib15","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/sj.thj.6200554","article-title":"Anti-CD20 monoclonal antibody rituximab for the treatment of B-cell chronic lymphocytic leukemia-associated pure red cell aplasia","volume":"5","author":"Pantelidou","year":"2004","journal-title":"Hematol J"},{"issue":"47","key":"10.1016\/j.leukres.2005.05.017_bib16","doi-asserted-by":"crossref","first-page":"7359","DOI":"10.1038\/sj.onc.1206939","article-title":"Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance","volume":"22","author":"Smith","year":"2003","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.leukres.2005.05.017_bib17","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1046\/j.1365-2141.2001.02873-4.x","article-title":"Treatment of refractory autoimmune haemolytic anaemia with anti-CD20 (rituximab)","volume":"114","author":"Ahrens","year":"2001","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.leukres.2005.05.017_bib18","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1046\/j.1365-2141.2001.02622-3.x","article-title":"Rituximab: a very efficient therapy in cold agglutinins and refractory autoimmune haemolytic anaemia associated with CD20-positive, low-grade non-Hodgkin's lymphoma","volume":"112","author":"Bauduer","year":"2001","journal-title":"Br J Haematol"},{"issue":"11","key":"10.1016\/j.leukres.2005.05.017_bib19","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1080\/1042819031000119235","article-title":"Anti-CD20 therapy for chronic lymphocytic leukemia-associated autoimmune diseases","volume":"44","author":"Zaja","year":"2003","journal-title":"Leuk Lymphoma"},{"issue":"12","key":"10.1016\/j.leukres.2005.05.017_bib20","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1182\/blood.V97.12.3995","article-title":"Anti-CD20 monoclonal antibody for the treatment of severe, immune-mediated, pure red cell aplasia and hemolytic anemia","volume":"97","author":"Zecca","year":"2001","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.leukres.2005.05.017_bib21","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/sj.thj.6200199","article-title":"Efficacy of rituximab in the treatment of refractory chronic lymphocytic leukemia patient with bone marrow aplasia","volume":"3","author":"Marotta","year":"2002","journal-title":"Hematol J"},{"issue":"3","key":"10.1016\/j.leukres.2005.05.017_bib22","doi-asserted-by":"crossref","first-page":"551","DOI":"10.3109\/10428190109064616","article-title":"Remarkable response to rituximab in a 72-year-old patient with refractory non-Hodgkin's lymphoma and marrow aplasia","volume":"42","author":"Egerer","year":"2001","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"10.1016\/j.leukres.2005.05.017_bib23","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/j.1365-2141.1994.tb06743.x","article-title":"Parvovirus B19 as a cause of acquired chronic pure red cell aplasia","volume":"87","author":"Frickhofen","year":"1994","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.leukres.2005.05.017_bib24","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1056\/NEJMra030840","article-title":"Parvovirus B19","volume":"350","author":"Young","year":"2004","journal-title":"N Engl J Med"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212605002079?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212605002079?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T10:35:10Z","timestamp":1586342110000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212605002079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["S0145212605002079"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2005.05.017","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}